OGN

Organon & Co. Healthcare - Drug Manufacturers - General Investor Relations →

YES
52.2% BELOW
↓ Approaching Was -50.6% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $17.19
14-Week RSI 60

Organon & Co. (OGN) closed at $8.21 as of 2026-02-02, trading 52.2% below its 200-week moving average of $17.19. This places OGN in the extreme value zone. The stock is currently moving closer to the line, down from -50.6% last week. The 14-week RSI sits at 60, indicating neutral momentum.

Over the past 199 weeks of data, OGN has crossed below its 200-week moving average 3 times. On average, these episodes lasted 63 weeks. The average one-year return after crossing below was -29.0%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $2.1 billion, OGN is a mid-cap stock. The company generates a free cash flow yield of 18.5%, which is notably high. Return on equity stands at 71.6%, indicating strong profitability. The stock trades at 2.4x book value.

Over the past 3.9 years, a hypothetical investment of $100 in OGN would have grown to $30, compared to $177 for the S&P 500. OGN has returned -26.3% annualized vs 15.6% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 7 open-market purchases totaling $1,153,381. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while OGN is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Growth of $100: OGN vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After OGN Crosses Below the Line?

Across 3 historical episodes, buying OGN when it crossed below its 200-week moving average produced an average return of -30.3% after 12 months (median -29.0%), compared to +12.3% for the S&P 500 over the same periods. After 24 months, the average return was -33.3% vs +38.7% for the index.

Each line shows $100 invested at the moment OGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Insider Buying Activity

1 conviction buy in the past 12 months (purchases over $500K with meaningful position increases). 🔥 Cluster Buy Detected

DateInsiderTitleValueSharesPosition +%
2025-11-12COX CARRIE SMITHOfficer and Director$501,75565,400+524.5%

Historical Touches

OGN has crossed below its 200-week MA 3 times with an average 1-year return of +-29.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 2022May 202221.1%-22.3%-69.7%
Jul 2022Jan 20232727.0%-35.8%-70.4%
Jan 2023Ongoing159+63.9%Ongoing-68.2%
Average63+-29.0%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02